{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:58:22Z","timestamp":1759971502726,"version":"build-2065373602"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T00:00:00Z","timestamp":1216771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Luminescence"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Streptozotocin (STZ)\u2010induced diabetes is linked to excessive nitric oxide (NO), and possibly peroxynitrite (OONO<jats:sup>\u2013<\/jats:sup>) and\/or other nitrogen oxides, e.g. nitrogen trioxide (N<jats:sub>2<\/jats:sub>O<jats:sub>3<\/jats:sub>), which damages DNA of pancreatic \u03b2 cells, causing death and loss of insulin. Simultaneous injection of carboxy\u2010PTIO (CPTIO) and STZ prevents diabetes and cataract formation in rats, whereas 4\u2010hydroxy\u2010Tempo (4HT) does not. CPTIO oxidizes nitric oxide to nitrite, which prevents production of the diabetogenic toxin. Peroxynitrite may not be involved, since 4HT (converts O<jats:sub>2<\/jats:sub><jats:sup>\u2013<\/jats:sup> to H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>) injected with STZ produces diabetes. All six of the control rats injected with STZ became diabetic and developed cataracts after 3 months. Eight rats injected with STZ and CPTIO were non\u2010diabetic with no cataracts up to a year. This work establishes the idea that excessive nitric oxide is a primary initiator in STZ diabetes. Luminescence experiments using OONO<jats:sup>\u2013<\/jats:sup> generation from SIN\u20101 with L\u2010012 indicates that 4HT is an effective inhibitor, while CPTIO is ineffective. Experiments with dilute solutions of nitrogen trioxide added to ladder or plasmid DNA reveal extensive nicking of DNA, thereby raising the possibility that other oxides of nitrogen could be involved with the damage to DNA. It can be concluded that diabetes can be prevented by oxidizing excessive NO from STZ. Copyright \u00a9 2008 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/bio.1050","type":"journal-article","created":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T12:13:21Z","timestamp":1216815201000},"page":"386-391","source":"Crossref","is-referenced-by-count":15,"title":["Luminescence experiments involved in the mechanism of streptozotocin diabetes and cataract formation"],"prefix":"10.1002","volume":"23","author":[{"given":"Knox","family":"Van Dyke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Ghareeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Van Dyke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Hoeldtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Van Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060244"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.10.1537"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.suppl_2.S87"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411243312107"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000076258"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.2641"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.8.8.8181671"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.8368"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000139268"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1271(199811\/12)13:6<339::AID-BIO501>3.0.CO;2-E"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/bio.959"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867053363207"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2005.04.030"},{"key":"e_1_2_1_15_2","first-page":"49","article-title":"The dual role of nitric oxide in islet \u03b2 cells","volume":"14","author":"Spinas GA.","year":"1999","journal-title":"News Physiol. Sci"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.6.2792"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(96)00407-8"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/diab.44.7.733","article-title":"Apoptotic cell death triggered by nitric oxide in pancreatic \u03b2 cells","volume":"44","author":"Kaneto H","year":"1995","journal-title":"Diabetes"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.4.706"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.5.2493"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021525"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.9.2817"},{"key":"e_1_2_1_23_2","first-page":"2491","article-title":"Aminoguanidine prevents peroxynitrite and cardiac hypertrophy in streptozotocin\u2010induced diabetic rats","volume":"145","author":"Stadler K","year":"2004","journal-title":"Orvosi Hetilap"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2004.10.062"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2005.02.010"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2005.03.031"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2004.09.001"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308317200"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03402167"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-003-0967-z"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI844"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6910com"},{"key":"e_1_2_1_33_2","first-page":"56","article-title":"Streptozotocin\u2010produced cataracts in rats","volume":"11","author":"White JH","year":"1972","journal-title":"Invest. Ophthalmol"},{"key":"e_1_2_1_34_2","unstructured":"FuchgottR IgnarroL MuradF.Nobel Prize in Physiology or Medicine 1998: Nobelprize.org"}],"container-title":["Luminescence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbio.1050","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bio.1050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T14:21:35Z","timestamp":1759933295000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bio.1050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,23]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1002\/bio.1050"],"URL":"https:\/\/doi.org\/10.1002\/bio.1050","archive":["Portico"],"relation":{},"ISSN":["1522-7235","1522-7243"],"issn-type":[{"type":"print","value":"1522-7235"},{"type":"electronic","value":"1522-7243"}],"subject":[],"published":{"date-parts":[[2008,7,23]]}}}